跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
AURO-ATOMOXETINE
Authorized
STANDARD
AURO-ATOMOXETINE
AURO PHARMA INC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
9153aa6a6a1f46c1
Company
AURO PHARMA INC
Type
Standard
Approval Details
Approval Id
9153aa6a6a1f46c1
Drug Approval Canada Name
AURO-ATOMOXETINE
Product Name
AURO-ATOMOXETINE
Status
Marketed
Status Date
2019-02-02
Original Market Date
2019-02-02
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
28:92.00
Atc Original
N06BA09 ATOMOXETINE
Aig Number
0150434005
Company Name
AURO PHARMA INC
Company Address
3700 Steeles Avenue West, Suite 402 Woodbridge Ontario Canada L4L 8K8
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
9153aa6a6a1f46c1
Type
Standard
Back to Health Canada Approvals
AURO-ATOMOXETINE - Health Canada Drug Approval Details